Synergistic cancer treatment
- 专利权人:
- Prolynx LLC
- 发明人:
- SANTI, Daniel V.,FONTAINE, Shaun
- 申请号：
- AU2019206623
- 公开号：
- AU2019206623A1
- 申请日:
- 2019.01.11
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要：
- Conjugates of topoisomerase I inhibitors linked to a macromolecule through a linkage that undergo beta elimination
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- METHOD OF TREATMENT USING FOLATE CONJUGATES AND TYROSINE KINASE INHIBITORS
- MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY
- CONNECTIONS OF PERIDEL INHIBITORS OF TRANSMISSION OF SIGNALS BY HEDGEHOG PROTEIN, METHOD OF THEIR RECEIVING, COMPOSITION AND METHODS OF TREATING CANCER AND INHIBITING ANGIOGENESIS AND HEDGEHOG IN CELLS
- TISSUE INHIBITOR OF METALLOPROTEINASE LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (GPI)-ANCHOR FOR TREATMENT OF CANCER AND SKIN LESION
- Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesions
